Trials / Completed
CompletedNCT05862090
A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
An Open Label, Multiple Dose, Crossover Clinical Trial to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 After Oral Administration in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years – 54 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the drug-drug interaction and safety of RLD2301 and RLD2007 after oral administration in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RLD2301 | Take it once a day per period. |
| DRUG | RLD2007 | Take it once a day per period. |
Timeline
- Start date
- 2023-04-05
- Primary completion
- 2023-05-26
- Completion
- 2023-05-26
- First posted
- 2023-05-17
- Last updated
- 2023-09-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05862090. Inclusion in this directory is not an endorsement.